Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond differently to medications.
Read More »Preventing H. Pylori Infections with Metformin
Use of metformin may decrease chances of developing gastric cancer in patients with T2D.
Read More »Safety and Efficacy of Metformin in Severe CKD
Study confirms recent guideline changes on metformin use in moderate-to-severe chronic kidney disease.
Read More »Metformin During Gestational Diabetes Increases Risk of Childhood Obesity
Long-term impact of intrauterine exposure to medication on the offspring remains unclear.
Read More »Non-adherence to Metformin Versus Therapeutic Failure: When is it Appropriate to Switch to Second-Line Therapies?
Patients who skipped initial treatment with metformin and were instead started on second-line antihyperglycemic medication more likely to need dual therapy or insulin to control T2.
Read More »Study Assesses Risk of Developing Diabetes, Reversing Prediabetes
Determining which patients benefit most from lifestyle, metformin interventions may improve individualized care decisions.
Read More »Diabetes Treatment Failure May Actually Be Nonadherence
Second-line treatment is often initiated without evidence of recommended use of first-line treatment.
Read More »Metformin For T1D Benefits – REMOVAL Study
The results of the REMOVAL study were presented at the 2017 European Association for the Study of Diabetes (EASD) in Lisbon
Read More »A New Perspective On Metformin Therapy In Type 1 Diabetes
The evolution of metformin therapy through the decades.
Read More »New Study Raises Questions about Metformin and Risk of Dementia and Parkinson’s
Study prompts more concerns for future seniors with diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.